Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2023-03-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于参加第八批全国药品集中采购拟中选的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 特一药业集团股份有限公司 regarding its participation and proposed selection in the eighth batch of national centralized drug procurement organized by a government office. It details the product involved, pricing, potential impact on the company, and risk warnings. The document is short (1621 characters), does not contain financial statements or detailed financial analysis, and is primarily an announcement of a business event related to procurement and sales channels. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is not a regulatory certification or legal proceeding. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2023-03-30 Chinese
关于公司董事兼高级管理人员股份减持计划时间过半的进展公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the progress of a shareholding reduction plan by a company director and senior management personnel. It details the status of the planned share sales, compliance with relevant regulations, and confirms no shares have been sold yet. There is no financial data, earnings information, or report publication mentioned. The content fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2023-03-24 Chinese
2023年第一季度业绩预告（更正后）
Earnings Release Classification · 95% confidence The document is titled as a '2023年第一季度业绩预告（更正后）' which translates to '2023 First Quarter Earnings Forecast (Corrected)'. It provides estimated financial performance for the period January 1, 2023 to March 31, 2023, including net profit and earnings per share projections. It explicitly states that the data is preliminary, unaudited, and based on internal estimates, with final detailed financial data to be disclosed in the official first quarter report. The document is short (1311 characters) and serves as an earnings forecast rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly/periodical financial results with key highlights only. Q1 2023
2023-03-22 Chinese
关于2023年第一季度业绩预告更正的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement correcting a previously disclosed quarterly earnings forecast for the first quarter of 2023. It states the correction of the forecast period dates and clarifies that the correction does not affect the company's financial condition or operating results. The document references the original forecast announcement and directs investors to the full corrected forecast on an external website. The document length is only 654 characters, which is very short and does not contain actual financial statements or detailed financial data. It is essentially a correction notice to a previously issued earnings forecast. According to the rules, such a brief correction announcement that refers to a forecast but does not contain substantive financial data itself should not be classified as an Interim/Quarterly Report (IR) or Earnings Release (ER). Instead, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and corrections that do not fit other categories.
2023-03-22 Chinese
独立董事关于相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion statement from the independent directors of a company regarding a specific matter about not exercising the early redemption right of convertible bonds. It references relevant laws and regulations and confirms compliance and approval procedures. The document is short (542 characters) and does not contain financial statements or detailed financial data. It is a formal opinion related to governance and regulatory compliance rather than a full report or announcement of voting results. This fits best under Regulatory Filings (RNS) as it is a compliance-related statement without substantive financial data or report content.
2023-03-21 Chinese
关于变更签字会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from a company about the change of its signing auditors for the 2022 financial report and internal control audit services. It details the replacement of specific certified public accountants and provides their professional background and compliance status. The document does not contain the audit report itself but informs about the change in auditors. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related information such as changes in signing auditors. The document length is short and it is not a report publication announcement or a certification letter, but an announcement about audit personnel changes related to the audit report. Therefore, the appropriate classification is AR with high confidence. FY 2022
2023-03-21 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.